MEETINGS - Regulatory Affairs Professional Society (RAPS) hosts the following conferences (Belgium) September 2002:
This article was originally published in Clinica
The Regulatory Affairs Professional Society (RAPS) is hosting two simultaneous conferences on Principles and Practices of Regulatory Affairs on September 12-13 2002 at the Sheraton Brussels Hotel & Towers, Brussels, Belgium. One will address EU regulatory affairs and the other US regulatory affairs. The EU course will review the fundamentals of the regulatory requirements for medical products in the EU. Topics include marketing authorisations, applicable directives, competent authorities, CE marking, notified bodies, future harmonisation efforts and proposed legislative changes. The US conference will contrast US regulatory requirements for drugs, medical devices and biologics. It will cover product development processes, preclinical and clinical considerations, marketing applications, post-marketing requirements and the enforcement of regulations across product lines. Further details from RAPS, on tel: +1 301 770 2920; fax: +1 301 770 2924; email: raps news @ raps . org www. raps. org
You may also be interested in...
A combined final opinion on the European Chemicals Agency’s proposed microplastic restriction is expected from ECHA committees by year-end, at which point the European Commission will consider whether and when microplastic must be removed from all leave-on cosmetic products marketed in the EU.
Butterfly Network’s CEO Laurent Faracci outlines the company’s growth strategy and plans for their “ultrasound-on-a-chip” technology after its merger with blank check company Longview Acquisition Corp. See what the company’s CEO said about it here.
CDC’s Advisory Committee on Immunization Practices votes 13-1 that these two groups be first in line for vaccination once FDA authorizes a vaccine and ACIP recommends it. Goal of vote is to guide health departments in placing vaccine orders.